Shailaja Kasibhatla

Shailaja Kasibhatla

Company: Boundless Bio

Job title: SVP

Seminars:

Unlocking the potential of CHK1: Discovery of BBI-355, the First ecDNADirected Therapy (ecDTx) for the Treatment of Oncogene Amplified Cancers 1:30 pm

• Addressing unmet need of oncogene driven cancers • Development of CHK1 inhibitor to disrupt cell cycle and cell survival in tumorsRead more

day: Day Two

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

 

Conferences Beacon
Intelligence

SEARCH

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.